Literature DB >> 9827352

An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.

A M Shoieb1, K A Hahn, M A Barnhill.   

Abstract

BACKGROUND: In this report we describe the establishment, characterization, and research utility of a cell line derived from a dog having a spontaneously occurring osteosarcoma.
MATERIALS AND METHODS: Tumor samples were collected from a dog with a naturally occurring osteosarcoma and processed for light microscopy, electron microscopy, immunocytochemistry, immunohistochemistry, karyology, and cell culture. Established cells from passage 31 (COS31; canine Qsteosarcoma cells from passage 31) were inoculated subcutaneously between the scapula and in the right abdominal side of athymic nude mice and evaluated similarly.
RESULTS: COS31 cells derived in cell culture and in nude mice had morphological and biochemical properties comparable in all respects to the original canine tumor specimen.
CONCLUSIONS: The ability of COS31 cells to produce tumors in nude mice (i.e. a small animal model) typical of canine osteosarcoma (i.e. a large animal model) with a similar pathological and biological behavior (e.g. alkaline phosphatase and osteocalcin positive immunostaining, osteoid production, rapid growth, and wide spread metastases) demonstrates the potential utility of COS31 cells as a in vitro and in vivo model system in the development of new strategies in the treatment of human osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827352

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  4 in total

1.  A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer.

Authors:  Dorothy Cimino Brown; Raymond Boston; James C Coyne; John T Farrar
Journal:  Pain Med       Date:  2008-09-24       Impact factor: 3.750

2.  The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.

Authors:  Kevin Marley; Stuart C Helfand; Wade A Edris; John E Mata; Alix I Gitelman; Jan Medlock; Bernard Séguin
Journal:  BMC Vet Res       Date:  2013-01-18       Impact factor: 2.741

3.  Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines.

Authors:  Jordan Ayers; Rowan J Milner; Galaxia Cortés-Hinojosa; Alberto Riva; Sandra Bechtel; Bikash Sahay; Matthew Cascio; Amandine Lejeune; Keijiro Shiomitsu; Carlos Souza; Oscar Hernandez; Marc Salute
Journal:  J Vet Diagn Invest       Date:  2021-01-15       Impact factor: 1.279

4.  Reference gene validation for gene expression normalization in canine osteosarcoma: a geNorm algorithm approach.

Authors:  Gayathri Thevi Selvarajah; Floor A S Bonestroo; Elpetra P M Timmermans Sprang; Jolle Kirpensteijn; Jan A Mol
Journal:  BMC Vet Res       Date:  2017-11-25       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.